The Healthline medical-review-board experiment, by the numbers

The Healthline medical-review-board experiment, by the numbers

The question: does attaching a named, credentialed reviewer to YMYL health pages move anything measurable, or is it cosmetic compliance theater?

Healthline's well-documented build-out gives us a usable data point. Across 2018-2020 the publisher layered a medical review network onto its library — roughly 100+ credentialed reviewers, a visible 'Medically reviewed by [Name, MD]' byline, and a dated last-review stamp. The 2017 QRG had just elevated 'reputation of the website and content creators' (section 2.6) and medical pages to highest-stakes YMYL.

The correlation often cited: Healthline's organic visibility climbed steeply through this window while several competitors without formal review pipelines flattened or fell after the August 2018 'Medic' update. Sistrix and SEMrush visibility curves from that period both show the divergence.

Counter-evidence worth holding: Healthline simultaneously expanded content volume, rebuilt its internal linking, and invested in original imagery. The review board did not ship in isolation.

Caveat: I have seen no controlled A/B where the only variable was reviewer attribution. The Medic update also rewarded sites already strong on independent reputation signals — third-party mentions, not on-page bylines.

What the case does establish: a credible, verifiable reviewer is a reputation signal a rater can confirm off-site. That is the mechanism the QRG actually describes — not the byline itself, but whether the named person is real and respected.

What we still don't know: how much of Healthline's recovery is attributable to attribution versus the surrounding overhaul, and whether the same byline on a no-name domain with no off-site reputation would have moved anything at all.